Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Phthalates and Phthalate Alternatives Have Diverse Associations with Oxidative Stress and Inflammation in Pregnant Women.

van T Erve TJ, Rosen EM, Barrett ES, Nguyen RHN, Sathyanarayana S, Milne GL, Calafat AM, Swan SH, Ferguson KK.

Environ Sci Technol. 2019 Mar 19;53(6):3258-3267. doi: 10.1021/acs.est.8b05729. Epub 2019 Mar 11.

PMID:
30793895
2.

Environmental contaminants and preeclampsia: a systematic literature review.

Rosen EM, Muñoz MI, McElrath T, Cantonwine DE, Ferguson KK.

J Toxicol Environ Health B Crit Rev. 2018;21(5):291-319. doi: 10.1080/10937404.2018.1554515. Epub 2018 Dec 24.

PMID:
30582407
3.

Urinary oxidative stress biomarkers and accelerated time to spontaneous delivery.

Rosen EM, van 't Erve TJ, Boss J, Sathyanarayana S, Barrett ES, Nguyen RHN, Bush NR, Milne GL, McElrath TF, Swan SH, Ferguson KK.

Free Radic Biol Med. 2019 Jan;130:419-425. doi: 10.1016/j.freeradbiomed.2018.11.011. Epub 2018 Nov 14.

PMID:
30445128
4.

Maternal Plasma Concentrations of Per- and polyfluoroalkyl Substances and Breastfeeding Duration in the Norwegian Mother and Child Cohort.

Rosen EM, Brantsæter AL, Carroll R, Haug L, Singer AB, Zhao S, Ferguson KK.

Environ Epidemiol. 2018 Sep;2(3). pii: e027. doi: 10.1097/EE9.0000000000000027.

5.

BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells.

Nathan S, Ma Y, Tomita YA, De Oliveira E, Brown ML, Rosen EM.

Breast Cancer Res Treat. 2017 Dec;166(3):681-693. doi: 10.1007/s10549-017-4442-y. Epub 2017 Aug 14.

6.

A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance.

Ma Y, Preet A, Tomita Y, De Oliveira E, Zhang L, Ueda Y, Clarke R, Brown M, Rosen EM.

Oncotarget. 2015 Dec 1;6(38):40388-404. doi: 10.18632/oncotarget.6323.

7.

New approaches to radiation protection.

Rosen EM, Day R, Singh VK.

Front Oncol. 2015 Jan 20;4:381. doi: 10.3389/fonc.2014.00381. eCollection 2014. Review.

8.

Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.

Ma Y, Tomita Y, Preet A, Clarke R, Englund E, Grindrod S, Nathan S, De Oliveira E, Brown ML, Rosen EM.

Mol Endocrinol. 2014 Dec;28(12):1971-86. doi: 10.1210/me.2014-1146.

9.

Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration.

Xu JY, Meng QH, Chong Y, Jiao Y, Zhao L, Rosen EM, Fan S.

Mol Clin Oncol. 2013 Mar;1(2):331-336. Epub 2012 Nov 20.

10.

Targeting the BRCA1/2 tumor suppressors.

Rosen EM, Pishvaian MJ.

Curr Drug Targets. 2014 Jan;15(1):17-31.

PMID:
24387337
11.

DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism.

Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, Sarkar FH, Brown ML, Dritschilo A, Rosen EM.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18650-5. doi: 10.1073/pnas.1308206110. Epub 2013 Oct 14.

12.

BRCA1 in the DNA damage response and at telomeres.

Rosen EM.

Front Genet. 2013 Jun 21;4:85. doi: 10.3389/fgene.2013.00085. eCollection 2013.

13.

Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis.

Xu JY, Meng QH, Chong Y, Jiao Y, Zhao L, Rosen EM, Fan S.

Oncol Rep. 2012 Dec;28(6):2264-70. doi: 10.3892/or.2012.2024. Epub 2012 Sep 11.

PMID:
22965493
14.

[EGFR-dependent impact of indol-3-carbinol on radiosensitivity of lung cancer cells].

Xiao X, Meng Q, Xu J, Jiao Y, Rosen EM, Fan S.

Zhongguo Fei Ai Za Zhi. 2012 Jul;15(7):391-8. doi: 10.3779/j.issn.1009-3419.2012.07.01. Chinese.

15.

Novel DNA damage checkpoint in mitosis: Mitotic DNA damage induces re-replication without cell division in various cancer cells.

Hyun SY, Rosen EM, Jang YJ.

Biochem Biophys Res Commun. 2012 Jul 6;423(3):593-9. doi: 10.1016/j.bbrc.2012.06.023. Epub 2012 Jun 13.

PMID:
22704936
16.

BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.

Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T.

PLoS One. 2012;7(6):e37697. doi: 10.1371/journal.pone.0037697. Epub 2012 Jun 1.

17.

High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanisms.

Wang LL, Meng QH, Jiao Y, Xu JY, Ge CM, Zhou JY, Rosen EM, Wang HC, Fan SJ.

Cancer Biother Radiopharm. 2012 Jun;27(5):329-35. doi: 10.1089/cbr.2012.1199. Epub 2012 Jun 1.

18.
19.

BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.

Hu XD, Meng QH, Xu JY, Jiao Y, Ge CM, Jacob A, Wang P, Rosen EM, Fan S.

Biochem Biophys Res Commun. 2011 Jan 28;404(4):903-9. doi: 10.1016/j.bbrc.2010.12.064. Epub 2010 Dec 21.

PMID:
21172304
20.

UHRF1 confers radioresistance to human breast cancer cells.

Li X, Meng Q, Rosen EM, Fan S.

Int J Radiat Biol. 2011 Mar;87(3):263-73. doi: 10.3109/09553002.2011.530335. Epub 2010 Nov 10.

PMID:
21067293
21.

BRCA1 regulation of base excision repair pathway.

Saha T, Smulson M, Rosen EM.

Cell Cycle. 2010 Jul 1;9(13):2471-2. doi: 10.4161/cc.9.13.12084. No abstract available.

PMID:
20581465
22.

Transcriptional regulation of the base excision repair pathway by BRCA1.

Saha T, Rih JK, Roy R, Ballal R, Rosen EM.

J Biol Chem. 2010 Jun 18;285(25):19092-105. doi: 10.1074/jbc.M110.104430. Epub 2010 Feb 25.

23.

BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA, Rosen EM.

Mol Endocrinol. 2010 Jan;24(1):76-90. doi: 10.1210/me.2009-0218. Epub 2009 Nov 3.

24.

Scatter factor protects tumor cells against apoptosis caused by TRAIL.

Fan S, Meng Q, Laterra JJ, Rosen EM.

Anticancer Drugs. 2010 Jan;21(1):10-24. doi: 10.1097/CAD.0b013e32832afc3b.

PMID:
19823077
25.

BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.

Ballal RD, Saha T, Fan S, Haddad BR, Rosen EM.

J Biol Chem. 2009 Dec 25;284(52):36083-98. doi: 10.1074/jbc.M109.025825. Epub 2009 Sep 21.

26.

Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides.

Ballal R, Cheema A, Ahmad W, Rosen EM, Saha T.

J Biomol Tech. 2009 Sep;20(4):190-4.

27.

Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms.

Li Y, Goodwin CR, Sang Y, Rosen EM, Laterra J, Xia S.

Anticancer Drugs. 2009 Oct;20(9):770-8. doi: 10.1097/CAD.0b013e32832fe472.

PMID:
19633536
28.

Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner.

Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM.

Cancer Res. 2009 Aug 1;69(15):6083-91. doi: 10.1158/0008-5472.CAN-08-3309. Epub 2009 Jul 21.

29.

Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.

Katiyar P, Ma Y, Riegel A, Fan S, Rosen EM.

Mol Endocrinol. 2009 Aug;23(8):1135-46. doi: 10.1210/me.2008-0347. Epub 2009 Apr 23.

30.

BRCA1 down-regulates cellular levels of reactive oxygen species.

Saha T, Rih JK, Rosen EM.

FEBS Lett. 2009 May 6;583(9):1535-43. doi: 10.1016/j.febslet.2009.04.005. Epub 2009 Apr 11.

31.

Inhibition of RNA polymerase III transcription by BRCA1.

Veras I, Rosen EM, Schramm L.

J Mol Biol. 2009 Apr 3;387(3):523-31. doi: 10.1016/j.jmb.2009.02.008. Epub 2009 Feb 11.

PMID:
19361418
32.

Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.

Hong YB, Kang HJ, Kim HJ, Rosen EM, Dakshanamurthy S, Rondanin R, Baruchello R, Grisolia G, Daniele S, Bae I.

Exp Mol Med. 2009 Mar 31;41(3):151-60. doi: 10.3858/emm.2009.41.3.018.

33.

BRCA1 Cross-Talk with Hormone Receptors.

Rosen EM, Ma Y, Fan S.

Cancer Treat Res. 2009;147:1-20. doi: 10.1007/978-0-387-09463-2_5. No abstract available.

PMID:
21461827
34.

Role of Src signal transduction pathways in scatter factor-mediated cellular protection.

Fan S, Meng Q, Laterra JJ, Rosen EM.

J Biol Chem. 2009 Mar 20;284(12):7561-77. doi: 10.1074/jbc.M807497200. Epub 2008 Dec 1.

35.

Microbeam radiation therapy: tissue dose penetration and BANG-gel dosimetry of thick-beams' array interlacing.

Dilmanian FA, Romanelli P, Zhong Z, Wang R, Wagshul ME, Kalef-Ezra J, Maryanski MJ, Rosen EM, Anschel DJ.

Eur J Radiol. 2008 Dec;68(3 Suppl):S129-36. doi: 10.1016/j.ejrad.2008.04.055. Epub 2008 Jul 7.

PMID:
18606516
36.

Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.

Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S, Laterra J.

Mol Cancer Res. 2008 Jan;6(1):139-50. doi: 10.1158/1541-7786.MCR-07-0236.

37.
38.

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.

Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, Furth PA.

Oncogene. 2008 Jan 31;27(6):794-802. Epub 2007 Jul 23.

39.

Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity.

Ma Y, Hu C, Riegel AT, Fan S, Rosen EM.

Mol Endocrinol. 2007 Aug;21(8):1905-23. Epub 2007 May 15.

PMID:
17505062
40.

Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.

Fan S, Meng Q, Laterra JJ, Rosen EM.

Oncogene. 2007 Jul 19;26(33):4774-96. Epub 2007 Feb 12.

PMID:
17297451
41.

Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.

Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM.

Oncogene. 2007 May 3;26(20):2925-38. Epub 2006 Nov 13.

PMID:
17099727
42.

Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.

Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM.

Anticancer Drugs. 2006 Aug;17(7):733-51.

PMID:
16926624
43.

Interlaced x-ray microplanar beams: a radiosurgery approach with clinical potential.

Dilmanian FA, Zhong Z, Bacarian T, Benveniste H, Romanelli P, Wang R, Welwart J, Yuasa T, Rosen EM, Anschel DJ.

Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9709-14. Epub 2006 Jun 7.

44.

Regulation of progesterone receptor signaling by BRCA1 in mammary cancer.

Katiyar P, Ma Y, Fan S, Pestell RG, Furth PA, Rosen EM.

Nucl Recept Signal. 2006;4:e006. Epub 2006 Apr 28.

45.

BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells.

Kang HJ, Kim HJ, Kim SK, Barouki R, Cho CH, Khanna KK, Rosen EM, Bae I.

J Biol Chem. 2006 May 26;281(21):14654-62. Epub 2006 Mar 27.

46.
47.

BRCA1 regulates gene expression for orderly mitotic progression.

Bae I, Rih JK, Kim HJ, Kang HJ, Haddad B, Kirilyuk A, Fan S, Avantaggiati ML, Rosen EM.

Cell Cycle. 2005 Nov;4(11):1641-66. Epub 2005 Nov 7.

PMID:
16258266
48.

BRCA1 in hormonal carcinogenesis: basic and clinical research.

Rosen EM, Fan S, Isaacs C.

Endocr Relat Cancer. 2005 Sep;12(3):533-48. Review.

PMID:
16172191
49.

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Ma Y, Katiyar P, Jones LP, Fan S, Zhang Y, Furth PA, Rosen EM.

Mol Endocrinol. 2006 Jan;20(1):14-34. Epub 2005 Aug 18.

50.

Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.

Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ, Weber B, Rosen EM, Pestell RG.

Cancer Res. 2005 Aug 1;65(15):6557-67.

Supplemental Content

Loading ...
Support Center